NR4A1 and cancer: In solid tumors, NR4A1 and NR4A2 are negative prognostic factors, they exhibit pro-oncogenic activities, and these can be inhibited by bis-indole derived compounds (CDIMs) which bind NR4A1 and NR4A2 and act as antagonists in cancer cells [31,32].